Utilize sequencing data as it pertains to identification and implementation of targeted therapeutics. |
|
|
|
|
|
Utilize sequencing data as it pertains to identification and implementation of clinical trials. |
|
|
|
|
|
Demonstrate understanding of genetic predisposition to cancer. |
|
|
|
|
|
Integrate principles of germline and somatic molecular sequencing of patients' germline and tumor samples. |
|
|
|
|
|
Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). |
|
|
|
|
|